Innovative modalities, such as antibody-drug conjugates (ADCs), radiopharmaceuticals (RPhs), and cell and gene therapies (CGTs), along with ultrahigh-concentration monoclonal antibody suspensions or high-concentration parenteral products, present unique contai... ...

请注册登录后继续浏览